Astellas Pharma Inc. (ALPMY)
OTC: ALPMY
· Real-Time Price · USD
11.33
0.15 (1.34%)
At close: Aug 15, 2025, 3:58 PM
11.30
-0.26%
After-hours: Aug 15, 2025, 03:58 PM EDT
Astellas Pharma Revenue
Astellas Pharma reported an annual revenue of $1,912.3B, reflecting a 19.25% growth. For the quarter ending March 31, 2025, Astellas Pharma generated $459.29B in revenue.
Revenue (ttm)
1,912.3B
Revenue Growth
19.25%
Price / Sales Ratio
1.36
Revenue / Employee
129.61M
Employees
14,754
Market Cap
20.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|